A recent study by Wang et al., however, has indicated that the full-length S protein of SARS-CoV-2 used for vaccine development induces nNAbs that increase the rate of ADE of infection by facilitating virus entrance into host cells that possess complement or Fc receptors and exacerbating the viral infection (178). This evidence concerns the gene PROS1 and viral infectious disease.